Tenaya Therapeutics (TNYA) Research & Development (2020 - 2026)

Tenaya Therapeutics' Research & Development history runs 7 years deep, the most recent figure standing at $14.8 million for Q1 2026.

• In Q1 2026, Research & Development fell 29.57% year-over-year to $14.8 million; the TTM figure through Mar 2026 stood at $62.4 million (down 24.64% YoY), while the FY2025 annual figure was $68.6 million, down 20.91% from the prior year.
• Research & Development was $14.8 million for Q1 2026 at Tenaya Therapeutics, roughly flat from $14.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $26.5 million in Q2 2023 to a low of $14.8 million in Q4 2025.
• Historically, Research & Development has averaged $21.3 million across 5 years, with a median of $22.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Research & Development soared 151.88% in 2022, then slipped 29.57% in 2026.
• A 5-year view of Research & Development shows it stood at $25.7 million in 2022, then decreased by 11.2% to $22.9 million in 2023, then decreased by 18.27% to $18.7 million in 2024, then retreated by 20.82% to $14.8 million in 2025, then rose by 0.3% to $14.8 million in 2026.
• The last three Research & Development figures came in at $14.8 million (Q1 2026), $14.8 million (Q4 2025), and $15.4 million (Q3 2025), per Business Quant data.